BIONICS - Pharmacokinetics (PK) Trial

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

September 30, 2021

Conditions
Heart Disease
Interventions
DEVICE

BioNIR Ridaforolimus Eluting Coronary Stent

Trial Locations (2)

49770

Cardiac and Vascular Research Center of Northern Michigan, Petoskey

85258

Scottsdale Heart Group, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medinol Ltd.

INDUSTRY

NCT02736344 - BIONICS - Pharmacokinetics (PK) Trial | Biotech Hunter | Biotech Hunter